RGNX
A.N. "Jerry" Karabelas, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About A.N. "Jerry" Karabelas, Ph.D.
REGENXBIO Inc. reported in an 8-K filed August 25, 2026 that A.N. "Jerry" Karabelas, Ph.D. resigned as director, effective August 25, 2026.
“On August 25, 2026, the Board also accepted the resignation of Jean Bennett, M.D., Ph.D. and A.N. "Jerry" Karabelas, Ph.D. from their positions as directors of the Company, effective August 25, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
REGENXBIO Inc. (RGNX)
SEC 8-K
Current2020-07-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at REGENXBIO Inc.
Other people whose current roles at this company are on record from its filings.
- Curran M. Simpson CEO, COO, Board Member
- Allan M. Fox Chairman, Board Member
- Kenneth T. Mills Chairman, Board Member
- Former EVP CFO
- Mitchell Chan Chief Accounting Officer
- Alexandra Glucksmann Board Member
- Alexandra Glucksmann, Ph.D. Board Member
- Curran Simpson Board Member
- Daniel Tassé Board Member
- David Stump Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.